ArticleScientific reports2026
DFT study of benzothiadiazole based small molecules for high efficiency organic photovoltaics.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- First-principles study to explore the long-range exciton dissociation and reduced binding energy in dicyanovinylene-indanone-based electron transport layers for PSCs.RSC advances · 2026Article
- Boosting hole-blocking and electron-transport properties in indacenodithiophene-based molecules.RSC advances · 2026Article
- DFT investigation of fluorination sites effects on the photovoltaic performance of D-π-A donor materials.Journal of molecular modeling · 2026Article
- Disentangling solvent effects on optical response via p-π and sp² lone-pair contributions in non-aromatic fused systems.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study employs density functional theory (DFT) and time-dependent DFT (TD-DFT) to design and evaluate eight novel non-fullerene acceptors (NFAs) (G1-G8) for organic solar cells (OSCs). The molecules were engineered through strategic terminal group modification of a reference indacenodithiophene (IDT)-benzothidiazole (BT) based structure. All designed systems exhibit substantially reduced bandgaps (1.73-2.00 eV) and redshifted absorption profiles (λ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.